ANAB
Price
$48.60
Change
-$0.03 (-0.06%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
1.52B
39 days until earnings call
Intraday BUY SELL Signals
XLO
Price
$9.01
Change
+$0.10 (+1.12%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
59.55M
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANAB vs XLO

ANAB vs XLO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ANAB vs. XLO commentary
Oct 02, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANAB is a StrongBuy and XLO is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
ANAB: Fundamental Ratings
ANAB
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
32
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
61
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANABXLO
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 15 days ago
80%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 5 days ago
80%
COMPARISON
Comparison
Oct 02, 2026
Stock price -- (ANAB: $48.63 vs. XLO: $8.91)
Brand notoriety: ANAB and XLO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANAB: 108% vs. XLO: 76%
Market capitalization -- ANAB: $1.52B vs. XLO: $59.55M
ANAB [@Biotechnology] is valued at $1.52B. XLO’s [@Biotechnology] market capitalization is $59.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANAB’s FA Score shows that 1 FA rating(s) are green while XLO’s FA Score has 1 green FA rating(s).

  • ANAB’s FA Score: 1 green, 4 red.
  • XLO’s FA Score: 1 green, 4 red.
According to our system of comparison, ANAB is a better buy in the long-term than XLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANAB’s TA Score shows that 4 TA indicator(s) are bullish while XLO’s TA Score has 4 bullish TA indicator(s).

  • ANAB’s TA Score: 4 bullish, 4 bearish.
  • XLO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ANAB is a better buy in the short-term than XLO.

Price Growth

ANAB (@Biotechnology) experienced а -5.94% price change this week, while XLO (@Biotechnology) price change was -1.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

ANAB is expected to report earnings on Nov 10, 2026.

XLO is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
ANAB
Daily Signal:
Gain/Loss:
XLO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCEC21.702.96
+15.80%
Capital Clean Energy Carriers Corp
ZG28.410.71
+2.56%
Zillow Group
QRHC1.35-0.01
-0.74%
Quest Resource Holding Corp
GILD147.50-1.55
-1.04%
Gilead Sciences
ANIK19.36-0.30
-1.53%
Anika Therapeutics